CMC Advises Keosys on sale of a majority stake to JMC Investment

CMC Advises Keosys on sale of a majority stake to JMC Investment

September 15, 2015

Paris, France –  CMC congratulates its client, Keosys on the sale of a majority stake of the company to JMC Investment.Keosys takes a significant step forward thanks to the acquisition of a majority stake of the company by JMC Investment. Mr. Jérôme Fortineau, Founder & CEO of Keosys SAS will reinvest alongside JMC.Following sustained annual growth of 20% over the past 3 years, Keosys adds resources and leadership that will allow the company to extend the product offering and grow its international presence. Keosys’ goal is to become the world leader of imaging diagnosis and imaging management solutions for nuclear medicine.


Keosys has been collaborating on clinical research with renowned International academic institutions for over 10 years and has more recently positioned itself as a challenger on the clinical trials market. Backed by a skilled and dedicated team of international experts, Keosys has developed innovative products and solutions for data collection and central reading services for medical imaging in the pharmaceutical industry.


Keosys will also continue to grow in the clinical routine market as a software publisher and a service provider. Keosys brings tools to the market that allows radiology and nuclear medicine departments to work closely together with one set of software resulting in more productivity and cost savings for clients (PACS solution, Teleradiology solutions, Tele-expertise platform, etc.).


“I am thrilled about this partnership with Jean-Marie Painvin and his team. This collaboration will be extremely valuable in helping Keosys execute its growth initiatives. This will also give my historical partners, at my side for 15 years, an opportunity to participate and give a fresh boost to our various industrial project” said Jérôme Fortineau.


About Keosys SAS

Since its creation in 2001, Keosys has built a rich expertise in medical imaging, telecommunication and IT. Backed by a skilled, dedicated and motivated team of experts, Keosys has developed innovative products and services utilized in medical diagnosis and clinical trials. In addition, Keosys’ newest innovation, VICToria (Virtual Imaging Clinical Trials), is an exciting Big Data project providing breakthrough advantages for clinical trials, diagnosis and clinical research. The Company is headquartered in Nantes (France) with operations in the United-States and Singapore.


About JMC Investment LLC

JMC Investment LLC is a family investment office focused on investing in small and midsized privately owned growth companies. JMC is based in New York and looks to invest with a long-term outlook on performance and an engaged partnership style. The Company has extensive experience in a multitude of sectors, transatlantic transactions, and advising management teams.


About CMC Consulting Group

The CMC Group is an international advisory firm providing integrated transaction services, management and medical affairs consulting and contract research to companies in the life science industries.  This integration provides clients a seamless interface between strategy and implementation and incorporates a range of perspectives designed to optimize engagement outcomes.  With offices in the United States, Asia and throughout the EU, the firm complements global industry knowledge with rich local market insight.